Locations
Company type
Result types
Industries
Employees
Founding year
The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Result configuration
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
Spidercore Inc.
Daejeon, South Korea
A
1-10 Employees
2020
Key takeaway
Spidercore's S.Core platform utilizes a hyper-scale AI engine to analyze nucleotides, aiming to enhance gene therapy development. Their focus on AI-driven decision-making in biomedical care promises improved accuracy and efficiency in clinical practices.
Reference
Core business
Spidercore Inc.
Brightonix Imaging
Pyeongtaek-si, South Korea
A
1-10 Employees
2016
Key takeaway
The company is a global leader in innovative biomedical imaging solutions, including AI applications, which may be relevant to advancements in AI drug discovery. Their expertise in imaging technologies like PET could enhance the drug development process.
Reference
Product
AI Solutions - products - BRIGHTONIX IMAGING
PET/MRI
Insilicogen
Yongin-si, South Korea
A
11-50 Employees
2005
Key takeaway
Insilicogen has built a robust bio big data infrastructure over the past 20 years, positioning itself as a leader in data production, archiving, modeling, and analysis, which are crucial processes in AI drug discovery.
Reference
Product
Solution | Insilicogen, Inc.
New Era for Bioinformatics
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
DongBangFTL
Hwaseong-si, South Korea
A
51-100 Employees
1990
Key takeaway
DongBangFTL is a leading company in the API industry, emphasizing its innovative research facilities and commitment to new drug development. With a strong export presence and established partnerships, they create an ecosystem for collaboration in the pharmaceutical sector.
Reference
Core business
DongbangFTL
AIRS Medical
Seoul, South Korea
A
11-50 Employees
2018
Key takeaway
AIRS Medical Inc. is revolutionizing the healthcare industry with its innovative, data-driven solutions, including an automated venipuncture system and an award-winning MRI enhancement technology. Their commitment to digital transformation and efficiency in medical procedures positions them as a key player in advancing healthcare delivery.
Reference
Core business
AIRS Medical Inc. – Official website of AIRS Medical Inc., Healthcare AI-Solution provider offering MRI Enhancement solution, Blood collection aid robits.
Onegene Biotechnology
Seongnam-si, South Korea
A
- Employees
2016
Key takeaway
Onegene Biotechnology is focused on advancing drug development, particularly through multi-target approaches, which may align with interests in AI drug discovery. Their expertise in dissecting disease microenvironments and developing multi-specific drugs positions them at the forefront of innovative treatment strategies.
Reference
Core business
ONEGENE BIOTECHNOLOGY
Mediwhale
Seoul, South Korea
A
11-50 Employees
2016
Key takeaway
The company focuses on early health risk detection through AI-powered retinal scans, which can predict various diseases, including cardiovascular and kidney conditions. Their Reti-Intelligence platform utilizes deep learning to analyze retinal images, providing a proactive approach to preventive healthcare.
Reference
Core business
Mediwhale | AI diagnostic solution
We believe that early detection is the best prevention. Our innovative diagnostic technology helps you take action before symptoms appear.
PROTEINA
South Korea
A
- Employees
2015
Key takeaway
Proteina is focused on developing innovative diagnostic strategies that enhance targeted treatment for cancer and other diseases. Their unique expertise in protein interactions may play a significant role in advancing precision medicine.
Reference
Core business
Proteina | Protein-Protein Interactions | About Us
Proteina creates novel technology that analyzes Protein-Protein-Interactions in new ways. Learn more about our company, our mission, and our technology.
BIORCHESTRA
Chungju-si, South Korea
A
1-10 Employees
2016
Key takeaway
At BIORCHESTRA, the focus is on developing innovative RNA medicines and delivery systems that address significant unmet medical needs, particularly in neurodegenerative and rare diseases. Their advanced technology enhances the targeted delivery of RNA therapeutics, which could be pivotal in the realm of drug discovery.
Reference
Core business
BIORCHESTRA – Innovative RNA Therapeutics
PI IP LAW
Seoul, South Korea
A
11-50 Employees
2013
Key takeaway
PI IP LAW highlights the innovative applications of artificial intelligence across various business sectors, emphasizing its potential beyond just internet or software companies. Their expertise in AI solutions positions them as key players in leveraging this technology for advancements in areas like drug discovery.
Reference
Service
Artificial Intelligence | PI IP LAW
The application of AI is not limited solely to internet or software companies, but it offers various opportunities for all business sectors and industries. At PI IP LAW, we understand the potential an ...
Technologies which have been searched by others and may be interesting for you:
The AI drug discovery industry in South Korea presents a rapidly evolving landscape marked by significant opportunities and unique challenges. One key consideration is the regulatory framework, which is becoming increasingly supportive of innovative technologies. The Ministry of Food and Drug Safety (MFDS) oversees the approval process, emphasizing the need for compliance with both national and international standards. Researchers and companies must also navigate challenges such as data privacy concerns and the integration of AI technology with traditional drug development processes. The competitive landscape is characterized by collaboration between academia and biotech firms, fostering a vibrant ecosystem for innovation. South Korea's strong investment in research and development, alongside government initiatives promoting digital healthcare, enhances the country’s global market relevance. However, companies should be aware of the potential environmental impacts associated with drug manufacturing and the importance of sustainable practices in their operations. In summary, those interested in the AI drug discovery sector should focus on understanding regulatory compliance, forging partnerships within the local ecosystem, and addressing sustainability issues to leverage the growing market effectively. Additionally, staying informed about global trends and advancements in AI technologies will be crucial for maintaining a competitive edge in this dynamic field.
Some interesting numbers and facts about your company results for Ai Drug Discovery
| Country with most fitting companies | South Korea |
| Amount of fitting manufacturers | 13 |
| Amount of suitable service providers | 4 |
| Average amount of employees | 11-50 |
| Oldest suiting company | 1990 |
| Youngest suiting company | 2020 |
Some interesting questions that has been asked about the results you have just received for Ai Drug Discovery
What are related technologies to Ai Drug Discovery?
Based on our calculations related technologies to Ai Drug Discovery are Biomedical (Red), Bioinformatics (Gold), Environmental Biotechnology (Grey), Agricultural Biotechnology (Green), Food Related Biotechnology (Yellow)
Which industries are mostly working on Ai Drug Discovery?
The most represented industries which are working in Ai Drug Discovery are Biotechnology, Medical, IT, Software and Services, Other, Human Resources
How does ensun find these Ai Drug Discovery Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.